Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 23, 2023 11:23 ET | Source: Research and Markets

XELJANZ for Ulcerative Colitis (UC) Pipeline Report 2023: Drug Market Insights and Forecasts, 2019-2032 - Focus on 7 Major Markets

Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "XELJANZ Market Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. "XELJANZ Market Drug...
November 01, 2023 08:18 ET | Source: Research and Markets

JAK Inhibitors Market Surges as Autoimmune Diseases Demand Cutting-Edge Solutions, 2032F: Revenues for Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, and Other Inhibitor Types

Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Janus Kinase (JAK) Inhibitors Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global Janus Kinase (JAK)...
October 17, 2023 05:18 ET | Source: Research and Markets

Global Tofacitinib Market Research Report 2023

Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Tofacitinib Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tofacitinib market is expected to grow...
May 04, 2022 16:53 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING LAW FIRM, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABBV

NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and August...
April 30, 2022 11:48 ET | Source: The Rosen Law Firm PA

ROSEN, A TOP RANKED FIRM, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ABBV

NEW YORK, April 30, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and...
April 20, 2022 10:28 ET | Source: The Rosen Law Firm PA

ABBV LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABBV

NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and...
April 09, 2022 15:06 ET | Source: The Rosen Law Firm PA

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABBV

NEW YORK, April 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...